These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 9211212

  • 1. Comparison of in vivo and in vitro measures of beryllium sensitization.
    Bobka CA, Stewart LA, Engelken GJ, Golitz LE, Newman LS.
    J Occup Environ Med; 1997 Jun; 39(6):540-7. PubMed ID: 9211212
    [Abstract] [Full Text] [Related]

  • 2. Significance of the blood beryllium lymphocyte proliferation test.
    Newman LS.
    Environ Health Perspect; 1996 Oct; 104 Suppl 5(Suppl 5):953-6. PubMed ID: 8933041
    [Abstract] [Full Text] [Related]

  • 3. Beryllium-stimulated neopterin as a diagnostic adjunct in chronic beryllium disease.
    Maier LA, Kittle LA, Mroz MM, Newman LS.
    Am J Ind Med; 2003 Jun; 43(6):592-601. PubMed ID: 12768609
    [Abstract] [Full Text] [Related]

  • 4. Major histocompatibility locus genetic markers of beryllium sensitization and disease.
    Saltini C, Richeldi L, Losi M, Amicosante M, Voorter C, van den Berg-Loonen E, Dweik RA, Wiedemann HP, Deubner DC, Tinelli C.
    Eur Respir J; 2001 Oct; 18(4):677-84. PubMed ID: 11716174
    [Abstract] [Full Text] [Related]

  • 5. Rocky Flats Beryllium Health Surveillance.
    Stange AW, Furman FJ, Hilmas DE.
    Environ Health Perspect; 1996 Oct; 104 Suppl 5(Suppl 5):981-6. PubMed ID: 8933045
    [Abstract] [Full Text] [Related]

  • 6. Beryllium health effects in the era of the beryllium lymphocyte proliferation test.
    Maier LA.
    Appl Occup Environ Hyg; 2001 May; 16(5):514-20. PubMed ID: 11370931
    [Abstract] [Full Text] [Related]

  • 7. Process-related risk of beryllium sensitization and disease in a copper-beryllium alloy facility.
    Schuler CR, Kent MS, Deubner DC, Berakis MT, McCawley M, Henneberger PK, Rossman MD, Kreiss K.
    Am J Ind Med; 2005 Mar; 47(3):195-205. PubMed ID: 15712254
    [Abstract] [Full Text] [Related]

  • 8. A Cluster of Beryllium Sensitization Traced to the Presence of Beryllium in Concrete Dust.
    Frye BC, Quartucci C, Rakete S, Grubanovic A, Höhne K, Mangold F, Gieré R, Müller-Quernheim J, Zissel G.
    Chest; 2021 Mar; 159(3):1084-1093. PubMed ID: 32926872
    [Abstract] [Full Text] [Related]

  • 9. Comparative analysis between CFSE flow cytometric and tritiated thymidine incorporation tests for beryllium sensitivity.
    Milovanova TN.
    Cytometry B Clin Cytom; 2007 Jul; 72(4):265-75. PubMed ID: 17328032
    [Abstract] [Full Text] [Related]

  • 10. Beryllium sensitization and disease among long-term and short-term workers in a beryllium ceramics plant.
    Henneberger PK, Cumro D, Deubner DD, Kent MS, McCawley M, Kreiss K.
    Int Arch Occup Environ Health; 2001 Apr; 74(3):167-76. PubMed ID: 11355290
    [Abstract] [Full Text] [Related]

  • 11. Assessment of the beryllium lymphocyte proliferation test using statistical process control.
    Cher DJ, Deubner DC, Kelsh MA, Chapman PS, Ray RM.
    Inhal Toxicol; 2006 Oct; 18(11):901-10. PubMed ID: 16864408
    [Abstract] [Full Text] [Related]

  • 12. Sarcoidosis and chronic beryllium disease: similarities and differences.
    Mayer AS, Hamzeh N, Maier LA.
    Semin Respir Crit Care Med; 2014 Jun; 35(3):316-29. PubMed ID: 25007084
    [Abstract] [Full Text] [Related]

  • 13. A model for optimization of biomarker testing frequency to minimize disease and cost: example of beryllium sensitization testing.
    Judd NL, Griffith WC, Takaro T, Faustman EM.
    Risk Anal; 2003 Dec; 23(6):1211-20. PubMed ID: 14641896
    [Abstract] [Full Text] [Related]

  • 14. Sensitization and chronic beryllium disease among workers in copper-beryllium distribution centers.
    Stanton ML, Henneberger PK, Kent MS, Deubner DC, Kreiss K, Schuler CR.
    J Occup Environ Med; 2006 Feb; 48(2):204-11. PubMed ID: 16474270
    [Abstract] [Full Text] [Related]

  • 15. The beryllium lymphocyte proliferation test: Relevant issues in beryllium health surveillance.
    Stange AW, Furman FJ, Hilmas DE.
    Am J Ind Med; 2004 Nov; 46(5):453-62. PubMed ID: 15490468
    [Abstract] [Full Text] [Related]

  • 16. Optimizing BeLPT criteria for beryllium sensitization.
    Middleton DC, Fink J, Kowalski PJ, Lewin MD, Sinks T.
    Am J Ind Med; 2008 Mar; 51(3):166-72. PubMed ID: 18181198
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of serial medical surveillance for chronic beryllium disease in a beryllium machining plant.
    Newman LS, Mroz MM, Maier LA, Daniloff EM, Balkissoon R.
    J Occup Environ Med; 2001 Mar; 43(3):231-7. PubMed ID: 11285871
    [Abstract] [Full Text] [Related]

  • 18. Beryllium disease among construction trade workers at Department of Energy nuclear sites: A follow-up.
    Cloeren M, Dement J, Gaitens J, Hines S, Diaz L, Tembunde Y, Cranford K, Shorter J, Mosier T, Ringen K, Beryllium in Construction.
    Am J Ind Med; 2022 Sep; 65(9):708-720. PubMed ID: 35833586
    [Abstract] [Full Text] [Related]

  • 19. Non-invasive diagnosis of chronic beryllium disease in workers exposed to hazardous dust in Israel.
    Fireman E, Mazor O, Kramer M, Priel I, Lerman Y.
    Occup Environ Med; 2010 Sep; 67(9):631-5. PubMed ID: 19955573
    [Abstract] [Full Text] [Related]

  • 20. Screening for beryllium disease among construction trade workers at Department of Energy nuclear sites.
    Welch L, Ringen K, Bingham E, Dement J, Takaro T, McGowan W, Chen A, Quinn P.
    Am J Ind Med; 2004 Sep; 46(3):207-18. PubMed ID: 15307119
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.